SOPHiA DDM vs Recursion Platform
AI-enhanced independent comparison — features, pros, cons, pricing and rankings.
Who each tool serves best — and when to pick the other one.
Healthcare providers, clinical laboratories, and researchers requiring precise genomic variant analysis for patient care.
- You need to analyze complex genomic data for clinical decision-making in healthcare.
- You want a cloud-based platform that integrates advanced variant detection algorithms.
- Your team requires a solution focused on oncology, rare diseases, and hereditary conditions.
Small clinics or users without genomic data expertise or those seeking fully transparent pricing and open-source solutions.
- You need an open-source genomic analysis tool with full code access.
- Free-tier limits are a blocker for your budget or scale requirements.
- You require detailed public pricing before committing to a platform.
The platform’s ability to deliver clinically validated genomic variant interpretations for precision medicine.
Biotech researchers and teams needing scalable AI-driven analysis of biological data to accelerate drug discovery.
- You need to analyze complex biological data with AI and automation at scale
- You want to accelerate drug discovery using integrated experimental and computational tools
- Your team requires a platform combining biology, imaging, and machine learning
Small startups or non-biotech users lacking experimental biology infrastructure or needing extensive API integrations.
- You need a simple out-of-the-box AI tool without biology expertise
- Free-tier limits are a blocker for your experimental throughput needs
- You require a public API for custom integrations and automation
Integration of high-throughput biology with AI for drug discovery workflows.
A canonical comparison across capabilities common to this category. Vendor-specific extras appear below in "Highlighted Features".
| Capability | SOPHiA DDM | Recursion Platform |
|---|---|---|
|
Free Tier Available
Usable without payment (with usage limits)
|
✓ | ✓ |
Each tool's marketing-listed features. Where a feature appears under one tool but not the other, it usually reflects how the vendor describes their product — not a definitive capability gap.
- Genomic Variant Detection — Identifies clinically relevant genetic variants
- Cloud-based Data Processing — Enables scalable and accessible genomic analysis
- Clinical Reporting — Generates reports tailored for healthcare decision-making
- Multi-Disease Support — Supports oncology, rare diseases, and hereditary conditions
- Data Security Compliance — Ensures compliance with healthcare data regulations
- High-throughput biology integration — Supports large-scale biological experiments and data capture
- Machine Learning Analysis — Applies AI models to interpret complex biological data
- Automation Workflows — Automates experimental procedures and data processing
- Data visualization — Provides tools for visualizing biological experiment results
- Collaboration Tools — Enables team collaboration on drug discovery projects
- Clinically validated genomic variant detection
- Cloud-based platform enabling easy access and scalability
- Supports multiple clinical applications including oncology
- User-friendly interface designed for healthcare professionals
- Strong focus on precision medicine workflows
- Integrated platform combining biology, automation, and AI
- Supports high-throughput experimental workflows
- Facilitates scalable drug discovery research
- Strong focus on biotechnology applications
- Enables data-driven insights from complex biological data
- Lack of publicly available pricing details
- Closed-source platform limits customization
- No public API for custom integrations
- Limited transparency on pricing and tiers
- Steep learning curve for non-biotech users
- Clinical genomic variant interpretation for oncology
- Rare disease genetic analysis and diagnosis
- Hereditary condition screening and reporting
- Research support for genomic data analysis
- Precision medicine decision support in healthcare
- Drug discovery research
- High-throughput biological screening
- Biotech experimental data analysis
- Machine learning-driven biology insights
- Automation of lab workflows
Natural languages each tool generates and understands. Primary languages are listed first.
What each tool can accept (input) and produce (output) — text, image, audio, video, code.
Offers a freemium model with basic access; advanced features and enterprise options require contacting sales.
-
Free
Free
Offers a freemium model with limited free access; paid tiers provide expanded features and capacity. Exact pricing details are not publicly disclosed.
-
Free
Free
Regulatory frameworks each tool claims compliance with (HIPAA, SOC 2, GDPR, etc.).
None listed.
Vendor-published numbers each tool highlights — usage scale, breadth, and operational stats. Different tools track different metrics, so direct row-by-row comparison usually isn't meaningful.
No metrics published.
- Experiment throughput increase 3x
Who each tool is positioned for — primary audience first.
How you can reach support — email, live chat, phone, community, docs.
- Documentation primary visit ↗
- Documentation primary
How each tool is classified in the Volvenix catalog.
These vocabulary domains are managed in our catalog but not yet exposed at the tool level. We're tracking them for future expansion of this comparison.
- Encryption Types — AES-256, ChaCha20, RSA-2048, and similar at-rest/in-transit cipher families.
- Encryption Contexts — where encryption is applied (data at rest, in transit, end-to-end).
- Plan-tier Model Mapping — which AI models are available on which pricing tier (currently only the model list is tracked, not the per-plan availability).
- What is this tool?
- SOPHiA DDM is a cloud-based platform that analyzes genomic data to identify clinically relevant genetic variants for healthcare professionals.
- How much does it cost?
- SOPHiA DDM offers a freemium model with basic access; advanced features and enterprise pricing require contacting sales.
- Does it have a free plan?
- Yes, there is a free plan providing basic access to core genomic analysis tools.
- What integrations does it support?
- Integration details are not publicly disclosed; the platform primarily operates as a cloud-based standalone solution.
- Who is it best for?
- It is best suited for healthcare providers, clinical labs, and researchers needing precise genomic variant analysis.
- What is this tool?
- Recursion Platform is a biotechnology AI tool that integrates biology, automation, and machine learning to accelerate drug discovery.
- How much does it cost?
- Recursion offers a freemium pricing model with limited free access; detailed paid pricing is not publicly disclosed.
- Does it have a free plan?
- Yes, Recursion provides a free plan with limited features suitable for individual users.
- What integrations does it support?
- The platform primarily integrates internally with biological and automation systems; no public API or third-party integrations are documented.
- Who is it best for?
- It is best suited for biotech researchers and teams needing scalable AI-driven analysis of biological data.
| Info | SOPHiA DDM | Recursion Platform |
|---|---|---|
| Pricing | Freemium | Freemium |
| Category | Healthcare & Medical AI | Healthcare & Medical AI |
| Deployment | Cloud | Cloud |
| Learning Curve | Intermediate | Advanced |
| Free Plan | ✓ | ✓ |
| AI Agent | ✗ | ✗ |
| Autonomy | Assistant | Copilot |
| Risk Tier | Medium | Medium |
Recursion Platform and SOPHiA DDM both offer freemium pricing models and have similar overall scores of 5.4/10 and 5.5/10, respectively. Recursion Platform focuses on drug discovery and biomedical research automation, providing tools for high-throughput screening and data analysis, while SOPHiA DDM specializes in genomic data interpretation and clinical decision support, targeting healthcare and diagnostics use cases.
ⓘ How Volvenix scores work
Scores are computed by Volvenix — not supplied by the vendors, and not third-party benchmark results. Each 0–10 dimension (Overall, Features, Usability, Support, Pricing) is a directional estimate aggregated from catalog signals — editorial cataloguing, content depth, engagement, and provider-reputation indicators — so treat them as a starting point, not a lab result.
Confidence reflects how complete the underlying data is for both tools; lower confidence means fewer signals were available, not a worse tool. We never accept payment for rankings or scores. More about how Volvenix works →